Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines.

作者: Lei He , Fan Wang , Wei-Qi Dai , Dong Wu , Chun-Lei Lin

DOI: 10.1016/J.PAN.2012.11.314

关键词:

摘要: Abstract Objectives Pancreatic cancer is one of the most aggressive and lethal cancers worldwide there are few effective treatments. Recently, salinomycin (Sal) was reported to alter proliferation apoptosis in various tumors. This prompted us investigate effect Sal on pancreatic cells explore possible molecular mechanism in vitro . Methods After treatment with Sal, cell viability were analyzed by Hoechst 33342 staining flow cytometry, respectively. Invasion metastasis assayed a Transwell migration assay. Flow cytometry also used assessed fraction CD133 + subpopulations. The expression proliferating nuclear antigen (PCNA), Bcl-2, E-cadherin, Wnt/β-catenin signaling-related proteins detected RT-PCR western blot. Results inhibited growth dose- time-dependent manner. We found that proportion subpopulations decreased after lines at same time. percentage apoptotic increased treatment. Compared control groups, Bax E-cadherin significantly upregulated, Bcl-2 PCNA downregulated Sal-treated cells. (β-catenin p-GSK-3β) inhibited. Conclusions These results indicate could influence , which may occur inhibition signaling.

参考文章(34)
Bence Sipos, Simone Möser, Holger Kalthoff, Virag Török, Matthias Löhr, Günter Klöppel, A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Archiv. ,vol. 442, pp. 444- 452 ,(2003) , 10.1007/S00428-003-0784-4
Han Sung Kang, Sungpil Yoon, Won Ki Kim, Ju-Hwa Kim, Kyungsil Yoon, Sunshin Kim, Jungsil Ro, Salinomycin, a p-glycoprotein inhibitor, sensitizes radiation-treated cancer cells by increasing DNA damage and inducing G2 arrest Investigational New Drugs. ,vol. 30, pp. 1311- 1318 ,(2012) , 10.1007/S10637-011-9685-6
Tao-Tao Dong, Hou-Min Zhou, Lin-Lin Wang, Bo Feng, Bo Lv, Min-Hua Zheng, Salinomycin Selectively Targets ‘CD133+’ Cell Subpopulations and Decreases Malignant Traits in Colorectal Cancer Lines Annals of Surgical Oncology. ,vol. 18, pp. 1797- 1804 ,(2011) , 10.1245/S10434-011-1561-2
Dongqing Wang, Haitao Zhu, Ying Zhu, Yanfang Liu, Huiling Shen, Ruigen Yin, Zhijian Zhang, Zhaoliang Su, CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Acta Histochemica. ,vol. 115, pp. 349- 356 ,(2013) , 10.1016/J.ACTHIS.2012.09.007
S Maeda, H Shinchi, H Kurahara, Y Mataki, K Maemura, M Sato, S Natsugoe, T Aikou, S Takao, CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer British Journal of Cancer. ,vol. 98, pp. 1389- 1397 ,(2008) , 10.1038/SJ.BJC.6604307
Heike Immervoll, Dag Hoem, Per Øystein Sakariassen, Ole Johnny Steffensen, Anders Molven, Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas BMC Cancer. ,vol. 8, pp. 48- 48 ,(2008) , 10.1186/1471-2407-8-48
Jing Li, M. Guillaume Wientjes, Jessie L.-S. Au, Pancreatic cancer: pathobiology, treatment options, and drug delivery Aaps Journal. ,vol. 12, pp. 223- 232 ,(2010) , 10.1208/S12248-010-9181-5
James M Wells, Farzad Esni, Gregory P Boivin, Bruce J Aronow, William Stuart, Chelsea Combs, Angela Sklenka, Steven D Leach, Andrew M Lowy, Wnt/β-catenin signaling is required for development of the exocrine pancreas BMC Developmental Biology. ,vol. 7, pp. 4- 4 ,(2007) , 10.1186/1471-213X-7-4
Desheng Lu, Michael Y. Choi, Jian Yu, Januario E. Castro, Thomas J. Kipps, Dennis A. Carson, Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 13253- 13257 ,(2011) , 10.1073/PNAS.1110431108